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Abstract 
Background: Public health measures are poised for transition from malaria control to malaria elimination on the 
island of Hispaniola. Assessment of the reservoir of asymptomatic infections from which acute malaria cases may 
derive is critical to plan and evaluate elimination efforts. Current field technology is ill suited for detecting sub‑
microscopic infections, thus highly sensitive survey methods capable of detecting virtually all infections are needed. 
In this study the prevalence of infection with Plasmodium falciparum was determined in patients seeking medical care 
primarily for non‑febrile conditions in six departments in Haiti using a newly designed qRT‑PCR‑based assay.
Methods: Three different methods of parasite detection were compared to assess their utility in approximating the 
prevalence of P. falciparum infections in the population: malaria rapid diagnostic test (RDT) designed to detect histidine‑
rich protein 2 (HRP2), thick smear microscopy, and a quantitative reverse transcription polymerase chain reaction (qRT‑
PCR) assay based upon the small sub‑unit ribosomal RNA. The limit of detection of the qRT‑PCR assay utilized was 0.0003 
parasite/µL of blood. Venous blood was obtained from a total of 563 subjects from six departments in Haiti, all of whom 
were seeking medical attention without complaints consistent with malaria. Each subject was questioned for knowledge 
and behaviour using demographic and epidemiological survey to identify risk factors for disease transmission.
Results: Among the 563 samples tested, ten and 16 were found positive for malaria by RDT and microscopy, respec‑
tively. Using the qRT‑PCR test to assess the infection status of these subjects, an additional 92 were identified for 
a total of 108. Based upon the qRT‑PCR assay results, a wide variation in prevalence of infection in asymptomatic 
subjects was seen between geographic locations ranging from 4–41 %. The prevalence of infection was highest in the 
Grand Anse, Nord and Sud‑Est Departments, and demographic data from questionnaires provide evidence for focal 
disease transmission.
Conclusions: The qRT‑PCR assay is sufficiently sensitive to identify an unexpectedly large number of asymptomatic, 
submicroscopic infections. Identifying and clearing these infections presents a significant challenge to both control 
and elimination efforts, but the qRT‑PCR assay offers a reliable method to identify them.
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Background
Hispaniola is the only Caribbean island where malaria 
is endemic, and the greatest burden is borne by Haiti, 
located on the western half of the island [1]. Anoph-
eles albimanus is the predominant vector transmitting 
malaria on Hispaniola, and the causative agent is Plas-
modium falciparum [2]. The national policy of the Hai-
tian Ministry of Health [Ministère de la Santé Publique 
et de la Population (MSPP)] is to screen individuals with 
symptoms consistent with malaria using one of the WHO 
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recommended rapid diagnostic tests (RDT); if positive, 
two slides each carrying thick and thin blood smear are 
obtained; one is read by local hospital technicians, while 
the second is sent to the national laboratory in Delmas 
[Laboratoire National de la Santé Publique (LNSP)] for 
confirmation. Although microscopy remains globally the 
gold standard for diagnosing malaria [3, 4], the accuracy 
of slide reading and their quality control remains ques-
tionable in Haiti [5]. Malaria remains high on the dif-
ferential list of non-respiratory acute febrile illnesses in 
Haiti, despite the fact that in recent studies only about 
3–17 % of these cases are confirmed as malaria by either 
microscopy or RDT [6, 7]. Official reporting of malaria 
cases to the LNSP is recognized as under-representing 
the true burden of malaria [2].
Since the vast majority of malaria cases on Hispaniola 
occur in Haiti, it should remain the focus of malaria con-
trol and future eradication efforts [2, 8, 9]. Eradication of 
malaria from Hispaniola is viewed as a reasonable goal, 
considering that it is an island isolated geographically 
from other malarious lands. Further, the disease is trans-
mitted by a comparatively poor, exophilic vector [10], and 
chloroquine-sensitive P. falciparum appears to be the 
single agent of malaria [2, 9, 11]. However, the effort to 
eliminate malaria on Hispaniola will face frequent natu-
ral disasters, poor infrastructure, lack of skilled labora-
tory technicians, and geographic barriers presented by 
mountainous terrain, combined with limited resources 
available to people seeking medical help and their nega-
tive perception of the value of the healthcare provided to 
them [12]. All of these factors have hampered past efforts 
at control [2].
Rapid diagnostic tests have been identified as a key 
component of the current control strategy to prepare 
for eradication, thus keeping microscopy as only a con-
firmatory secondary test [13]. RDTs have a ≥75  % sen-
sitivity at 200 parasites/µL of blood [14] with a false 
positive rate ≤10 % and an invalid rate ≤5 %, according 
to WHO published guidelines. In July 2010 Haiti MSPP 
approved the use of three RDTs in the country: First 
Response Malaria Ag HRP2 (Premier Medical Corpora-
tion Ltd., Watchung, NJ, USA), CareStart Malaria HRP2 
(Pf ) (Access Bio, Inc, Monmouth Junction, NJ, USA), and 
SD Bioline Malaria Ag Pf (Standard Diagnostics, Inc., 
Yongin, Korea) [15].
Moving beyond the malaria control phase to the elim-
ination phase, it is suspected that in comparison to the 
whole population carrying malaria parasites, the febrile 
cases represent only the tip of the iceberg. The sub-popu-
lation harbouring asymptomatic, sub-microscopic infec-
tions remains obscure. A recent review has described the 
potential for P. falciparum to persist in an asymptomatic 
host for more than a decade, making these infections 
potentially very important in elimination efforts [16]. 
Further, the importance of these asymptomatic infec-
tions rises when transmission levels are low such as in 
Haiti, where the overall official prevalence seems to range 
between 0.1–1  % [2, 17]. Despite the low prevalence of 
febrile cases, multiple studies have pointed out the high 
prevalence of asymptomatic carriers using only micros-
copy for diagnosis [7, 18]. Additional sub-microscopic 
infections remain unidentified, and will require imple-
menting new survey tools capable of identifying them.
For the past five years malaria transmission in Haiti has 
been fairly stable, with a promising low level of overall 
transmission. However, in Africa and other areas around 
the world   where the transmission levels drop signifi-
cantly, substantial numbers of sub-microscopic carri-
ers remain, enabling the parasite to restart transmission 
when conditions are right [19–22]. In Tanzania, the prev-
alence of asymptomatic malaria infections as determined 
by microscopy was 1.9  %, whereas by real-time quanti-
tative nucleic acid sequence-based amplification with a 
lower limit of detection, it was 32.5 % [22]. In this study 
a scheme is presented for testing field-collected samples 
from remote and undeveloped areas in Haiti to identify 
sub-microscopic infections using qRT-PCR in an attempt 




This study was conducted in accordance with institu-
tional review board guidelines and requirements of the 
University of Florida and the ethical review board of the 
Haitian MSPP after obtaining all permits and approvals 
(UF IRB 201400202; UF IRB201400224; MSPP Ref. 1314-
12; MSPP Ref. 1314-62). Subjects were recruited through 
a cross-sectional sampling of reproductive age women 
across Haiti in gynecology and maternity clinics. Study 
team collaborated with NGOs and government dispen-
saries to enrol women for free malaria screening. Each 
participant during the waiting time for enrolment was 
asked to answer a demographic survey in Haitian Cre-
ole. The questionnaire included general demographic and 
behaviour questions such as gender, age, geographic resi-
dency, history of travel, sleeping pattern (outdoor and/or 
indoor), presence of window screens, use of insecticide-
treated bed nets, presence of bed nets whether treated or 
not, and history of malaria transmission for the partici-
pant and household members. Each questionnaire was 
labelled with a unique identifying number that matched 
the consent form and sample to provide de-identified 
data for analysis.
Study sites shown in Fig.  1 were selected to cover 
diverse settings across the entire country of Haiti, 
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including areas of high and low transmission. Subjects 
living in rural sites located in six of the ten departments, 
(Artibonite, Central Plateau, Grand Anse, Nord, Ouest, 
Sud-Est) were screened. Historically, malaria transmis-
sion has been reported in the Nord, Artibonite and 
Sud-Est Departments, and Grand Anse experienced an 
elevated level of transmission beginning in July 2014. In 
contrast, the Ouest and Central Plateau were known to 
be areas of low transmission. Between August 2014 and 
March 2015 a total of 563 venous blood samples were 
collected in an EDTA-coated, purple-top Vacutainer 
tube from attendants of maternity and gynecology clin-
ics. Blood was mixed gently within the collection tube 
and 400 µL were transferred in a cryotube pre-filled with 
1200  µL of DNA/RNA Shield™ (DRS, ZymoResearch, 
Inc.) for preservation of RNA and DNA. Approximately 
25–50  µL of blood were used to make two microscopic 
slides (thick and thin smear) and run a CareStart Malaria 
HRP2 RDT. RDT results were recorded immediately 
in a study logbook. Microscopic slides were left to air-
dry then Giemsa stained, following CDC protocol [23]. 
Whole blood in DRS was maintained at 4  °C or on wet 
ice continuously until placed at −20  °C upon return to 
the University of Florida laboratory in Gressier. The aver-
age travel time for the study team for sample collection, 
storage and sample freezing ranged from five to 15 days. 
Samples were shipped frozen on blue ice to the Univer-
sity of Florida, Gainesville, FL, USA.
qRT‑PCR assay design
A set of primers and a probe were designed to develop 
a highly sensitive molecular test to detect the presence 
of P. falciparum small sub-unit ribosomal RNA type A 
[24, 25]. These reagents were developed by aligning the 
small sub-unit rRNA gene sequences from the four most 
common Plasmodium spp. infecting humans (Plasmo-
dium ovale, P. falciparum, Plasmodium malariae, Plas-
modium vivax) along with human small sub-unit rRNA 
using ClustalW2 software, and selecting specific primer 
pairs and probe using Integrated DNA Technologies, 
Inc. software. Care was taken to assure that the primers 
and probe would detect the small sub-unit rRNA, which 
is present predominantly in P. falciparum blood stage 
parasites. The following primers were selected for use in 
Fig. 1 Geographic location of enrollment sites
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the qRT-PCR assay employed here: forward (5-GATAC-
CGTCGTAATCTTAACCATAAAC-3), reverse 
(5-AAGGTACTGAAGGAAGCAATCT-3) and probe 
(6-FAM-ACACTTTCATCCAACACCTAGTCGGC-
BHQ-1). The specificity of the primers was confirmed 
experimentally with RNA from P. falciparum clone 3D7 
and RNA from uninfected human blood.
Sample processing and qRT‑PCR assay
Total RNA was extracted from 800 µL of the mixture of 
blood preserved in DRS using the Quick-RNA™ Mini-
Prep Kit following the RNA isolation from red blood cells 
protocol (Zymo Research) in a PCR workstation. The 
RNA was eluted in a volume of 50 µL of which 5 µL was 
used in the qRT-PCR reaction. Total nucleic acid extrac-
tion was also performed from blood samples in DRS 
using the same kit, but following a modification recom-
mended by the manufacturer for obtaining total nucleic 
acids. Total nucleic acids were also eluted in 50  µL of 
which 5 µL was used in subsequent qPCR and qRT-PCR 
reactions.
The qRT-PCR was conducted using the Express One-
Step SuperScript qRT-PCR Kit (Invitrogen) following 
manufacturer’s instructions with a final concentration 
of 0.4 µM of each primer and 0.2 µM for the probe in a 
20  µL reaction. The PCR master mix preparation was 
conducted in a separate PCR work station. Amplifica-
tion and real-time measurements were performed on a 
CFX96 Touch ™ Real-Time PCR Detection system (Bio-
Rad). Reaction conditions were as follows: 20  min at 
58 °C for reverse transcription step, one cycle of 2 min at 
95 °C for Taq DNA Polymerase activation and 40 cycles 
of 95 °C for 15 s, 60 °C for 1 min for annealing and exten-
sion of amplified product. Every PCR run was conducted 
with two negative controls and one positive control. Sam-
ples were tested in separate batches where those with 
positive RDT results were extracted and tested separate 
from the ones with negative RDTs to reduce the possibil-
ity of cross contamination.
In vitro limit of detection
A synchronous culture of P. falciparum 3D7 free of 
mature parasites and most culture debris was prepared 
as follows to obtain parasitized cells containing ring 
stage parasites, the developmental stage expected in the 
peripheral blood of infected patients. A fresh, semi-syn-
chronous culture was prepared by the sorbitol method 
[26] and mature schizonts collected on a magnetic col-
umn [27]. The mature schizonts were released from the 
column and incubated with fresh red blood cells for 
12–15  h to allow release of merozoites and re-invasion. 
The mature parasites that had not released merozoites 
were removed using a second magnetic column. The 
parasitaemia of the ring stage parasites in culture which 
passed through the column was determined using both 
microscopy and fluorescence activated cell sorting, and 
the number of parasites per volume of culture calculated 
based upon the number of red blood cells per volume 
of culture determined using a Coulter counter. Counted 
parasitized red cells from culture were mixed with whole 
human blood to prepare an initial sample containing 105 
parasites/ml.
A standard curve was prepared from RNA extracted 
from the initial sample containing 105 parasites/ml and 
serially diluted in RNase/DNase free water in intervals 
of tenfold dilution with the final dilution equivalent to 
0.1 parasites/ml of blood. All dilutions were treated with 
RNase inhibitor using RNase Out (Life Technologies) 
with a final concentration of 1 unit per µL. The same 
blood sample having 105 parasites/ml was serially diluted 
as well in un-infected blood at intervals of ten-fold to 
reach a concentration of 10 parasites/ml of blood, then 
at intervals of two-fold dilution until reaching a con-
centration of 0.3 parasites/ml of blood. Infected blood 
(200 µL) was then mixed with 600 µL of DRS and RNA 
was extracted from all 800 µL as described above. RNA 
was eluted in a volume of 50 µL, of which 5 µL was used 
as a template in each qRT-PCR reaction.
Statistical analysis
Demographic and survey items were used to assess differ-
ences in the likelihood of being an asymptomatic carrier 
of P. falciparum parasites. After stratification for demo-
graphic location by department, simple logistic regres-
sion models were used to determine the likelihood of 
carrying P. falciparum parasites using survey questions in 
Stata V.11 (Statacorp, College Station, TX, USA). Ques-
tions included items relating to participant knowledge of 
malaria, risk factors for malaria infection, demographic 
characteristics, and human mobility characteristics. Sta-
tistical significance was determined at an alpha level of 
0.05 in all logistic regression models.
Results
Using the synchronized ring stage cultured parasites in 
a series of blood dilutions, the limit of detection of the 
qRT-PCR assay for P. falciparum was 0.0003 parasitized 
red cells per µL of whole blood (0.3 per mL) (Fig. 2a). In 
testing serial dilutions of RNA extracted from a blood 
sample with a higher parasitaemia, the results were highly 
correlated with RNA extracted from the blood dilution 
series, however the limit of detection for the diluted RNA 
was even lower, 0.0001 parasitized red cells per µL (0.1 
per mL) (Fig. 2b). Assays to determine the limit of detec-
tion of this method were conducted three times indepen-
dently with parasites from in vitro culture to demonstrate 
Page 5 of 9Elbadry et al. Malar J  (2015) 14:510 
reproducibility before using it with field-collected sam-
ples. The standard curve obtained using RNA extracted 
from the blood dilution series (Fig. 2a) was used to esti-
mate the parasitaemia of all field samples (Fig. 2c), since 
extraction of RNA from the blood samples used to pre-
pare this curve most closely corresponds to the prepa-
ration of RNA from the field samples. Samples were 
collected from rural sites in six departments across Haiti, 
and all samples were tested for malaria parasites using 
RDT, microscopy and qRT-PCR. Among the 563 samples 
tested, ten and 16 were found positive for malaria by RDT 
and microscopy, respectively. Using the qRT-PCR test to 
assess the infection status of these subjects, an additional 
92 were identified for a total of 108. The majority (55.6 %) 
of these infections hosted a parasitaemia of less than one 
parasite per ml of blood (Fig. 2c). Results by department 
for all tests are shown in Table 1. All samples testing posi-
tive by the qRT-PCR were re-extracted for total nucleic 
acid using a modified protocol of the same extraction kit 
as per the manufacturer’s protocol. The assay was then 
repeated using the same reaction conditions with and 
without the reverse transcription step to evaluate the dif-
ference in detecting rRNA and genomic DNA, respec-
tively. By qPCR only 20 of the 108 qRT-PCR-positive 
samples were identified as positive.
Overall 3.0  % of samples tested were positive for 
malaria by microscopic analysis, 2.4 % by RDT and 19.1 % 
by qRT-PCR. However, a large variation in prevalence 
of infection was detected across departments. Depart-
ments having a low prevalence of malaria infections (i.e., 
fewer than five sub-microscopic carriers per 100 in the 
population) are Artibonite, Central Plateau and Ouest. 
High prevalence (i.e., more than 20 sub-microscopic car-
riers per 100 in the tested population) was observed in 
the Nord, Sud-Est and Grand-Anse Departments. Thus, 
a large reservoir of asymptomatic, sub-microscopic car-
riers is present in various locations across the peninsula 
interspersed with departments with very low prevalence.
No significant risk factors emerged from the regression 
analysis for insecticide usage nor did sleeping outdoors 
during morning or night correlate with a positive qRT-
PCR result. However, travelling outside the screening 
area within the last month was shown to be a protective 
factor with odds ratio of 0.53 and (P = 0.004). Those who 
were qRT-PCR-positive were more likely to know about 
malaria as a disease and its mode of transmission, with 
an odds ratio of 1.79 (P = 0.009). The odds of being posi-
tive for malaria by qRT-PCR when a household member 
was also infected were 2.2 times higher than for those 
who did not live near a malaria-infected family member, 
and this relationship was found to be statistically signifi-
cant with a (P = 0.002). Lastly, the odds of being positive 
by qRT-PCR with a history of previous infection was 2.1 
times higher than for those who were self-identified as 
not previously having been infected (P = 0.003). A sum-
mary of results for the demographic questionnaire is pre-
sented in Table 2.
Fig. 2 Estimating parasitaemia by qRT‑PCR in field samples using 
standard curves generated from in vitro cultured ring stage parasites. 
a Standard curve by serial blood dilution; b standard curve combined 
serial dilution of blood and RNA; c distribution of positive samples by 
parasitaemia
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Discussion
A survey method capable of identifying virtually every 
individual infected with the parasite will be crucial in the 
malaria elimination phase. It will allow making a reliable 
estimate of the proportion of sub-microscopic infections 
which must be factored in when developing intervention 
plans (e.g., mass drug administration or test and treat), 
and, secondly to test the efficacy of intervention meas-
ures after implementation to evaluate success [22]. PCR 
has been extensively used as the most sensitive survey 
tool with a detection limit of 0.01–0.2 parasites/µL of 
blood [20]. PCR depends on detecting genomic DNA, 
commonly a segment of the small sub-unit ribosomal 
RNA gene due to its multiple copy numbers and avail-
ability of relatively conserved regions. The power of 
detecting the ribosomal RNA itself has been recognized 
by others [22, 28–32], and by qRT-PCR the limit of detec-
tion is as low as 0.0003 parasites/µL of blood, as reported 
here. The limited use of qRT-PCR rather than conven-
tional one step or nested PCR can be attributed to factors 
such as the potential challenge of maintaining RNA qual-
ity and the increased cost of using a probe-based assay. 
The value of the extremely low limit of detection offered 
by the qRT-PCR test employed here is seen in the large 
number of asymptomatic carriers identified which were 
undetected by any other method, including qPCR.
Table 1 Performance of  qRT-PCR compared to  microscopy, and  RDT with  blood sample obtained from  asymptomatic 
population
Location RDT Slide RT‑PCR
Department (n) No. Pos. % Pos. (n) No. Pos. % Pos. (n) No. Pos. % Pos.
Artibonite 108 0 0 108 0 0 108 3 2.8
Central Plateau 122 0 0 122 0 0 122 6 4.9
Grand Anse 194 10 5.1 194 14 7.1 194 79 40.7
Nord 39 0 0 39 1 2.6 39 10 25.6
Ouest 63 0 0 63 0 0 63 2 3.2
Sud‑Est 37 1 2.7 37 2 5.4 37 8 21.6
Total 563 14 2.4 563 17 3.0 563 108 19.1
Table 2 Logistic analysis of demographic factors for malaria parasite transmission
Exposure factors Survey response n Proportion Likelihood of positive qRT‑PCR result
OR P value 95% CI OR
Bednet use No 482 35.1 Ref – – –
Yes 64.9 1.49 0.099 0.927 2.409
Insecticide use No 435 78.2 Ref – – –
Yes 21.8 0.93 0.803 0.528 1.639
Sleeping outside No 450 62 Ref – – –
Yes 38 1.35 0.192 0.861 2.116
Has window nets No 462 90.7 Ref – – –
Yes 9.3 1.08 0.845 0.512 2.267
Travel history No 510 46 Ref – – –
Yes 54 0.53 0.004 0.345 0.817
Knowledge of malaria No 490 61.2 Ref – – –
Yes 38.8 1.79 0.009 1.154 2.782
History of infection No 502 79.7 Ref – – –
Yes 20.3 2.12 0.003 1.297 3.460
Household member infected No 355 70.1 Ref – – –
Yes 29.9 2.21 0.002 1.339 3.633
History of treatment No 387 73.9 Ref – – –
Yes 26.1 2.13 0.003 1.284 3.538
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The qRT-PCR assay described here has the potential to 
detect blood stage infections from the first emergence of 
the parasite into the blood from the liver throughout the 
course of blood stage infection, even during what appears 
to be an asymptomatic, chronic phase. A single exo-
erythrocytic (EE) stage schizont releases merosomes into 
the blood stream, which ultimately rupture releasing tens 
of thousands of merozoites. Assuming an average blood 
volume of 5 L and a single exoerythrocytic stage schizont 
releasing merozoites, then two or more infected red cells 
may be expected per ml of blood to initiate the asexual 
growth phase. To detect this parasitaemia, the test must 
have a limit of detection equal to or lower than 0.004 
parasites/µL of blood. The qRT-PCR targeting the small 
ribosomal RNA of P. falciparum with a limit of detection 
of 0.0003 parasites/µL of blood exceeds this threshold by 
an order of magnitude. Comparing the qRT-PCR assay to 
qPCR on total nucleic acids using the same primer sets 
and reaction conditions, excluding the reverse transcrip-
tion step, Ct values for qRT-PCR were an average of 14 
lower than for qPCR for the same sample. The large num-
ber of rRNA molecules in each parasite (>104) [33], their 
presence in free merozoites, and the fact that they are 
packaged separately in ribosomes which may be released 
as separate particles upon cell lysis, all likely contribute to 
the ability to detect as few as three parasitized red blood 
cells per 10 ml of blood, even when sampling only 0.4 ml 
of blood and ultimately assaying RNA from only 5 % of 
the blood sample.
In order for Haiti to reach the pre-elimination phase of 
malaria, the number of active cases must be less than one 
per 1000 population at risk in preparation for a reduction 
to zero locally acquired cases. Haiti would have to main-
tain zero locally acquired cases for at least 3 years prior 
to becoming certified malaria-free country by WHO 
[34]. The current status seems ambiguous, since official 
records indicate a reduced overall number of clinical 
cases from  ~80,000 in 2010 to  ~17,000 in 2014 [6] and 
hyperendemic foci of malaria remain despite current 
control efforts [7, 18]. All official published data acquired 
from hospitals and dispensaries across Haiti represent 
only data from febrile cases, yet in an area experiencing 
high transmission only 17 % of all acute febrile illnesses 
were attributed to malaria [7].
Comparatively high malaria prevalence has been 
reported previously in the Grande Anse, Nord and Sud-
Est Departments [7, 18], however, none of the reported 
data accurately captured the sub-microscopic levels of 
infection. There is no national policy on active cross-sec-
tional surveillance to monitor number of asymptomatic 
or sub-microscopic carriers of parasite in the country. 
Needless to say Haiti currently has no tools available to 
identify the sub-microscopic population, but counting 
the sub-microscopic infections found in these depart-
ments raises the already high prevalence to a remark-
ably high level. Over the past few years there has been an 
elevated level of malaria transmission in Grand-Anse. A 
community-based survey there found that gametocytes 
were rare in the asymptomatic population (0.9  %) [7], 
however the survey methods used to detect gametocytes 
have the same higher limit of detection as microscopy for 
malaria diagnosis as described here. Thus, it is expected 
that a higher percentage of gametocytaemic individu-
als would have been found in this population, if assessed 
by PCR-based methods. In the present study 40 % of the 
asymptomatic population in the same area were infected 
with the parasite. In spite of the low levels of parasitae-
mia in this population, it is likely over time that they pro-
duce gametocytes in sufficient quantities to contribute in 
disease transmission [20]. Given the large percentage of 
individuals having such a low parasitaemia (Fig. 2c), it is 
highly likely that they have chronic infections, with only a 
small fraction sampled at the very onset of a new malaria 
infection. Despite this logic, whether the parasites were 
persistently present in the blood stream from a previ-
ous infection or recurrent re-infections is yet to be stud-
ied. Further, the methodology used does not necessarily 
detect only viable parasites, rather stable nucleic acids 
derived therefrom, thus further analysis is required to be 
able to accurately estimate the parasite burden in individ-
uals positive by the qRT-PCR test. The study is also lim-
ited having screened only females of child-bearing age. 
Whether or not the same level of high prevalence is seen 
in males, elders and children in the population requires 
further investigation.
In spite of the availability of bed nets to 64  % of the 
population, no statistical significance for their proposed 
role in protecting individuals from infection was found. 
This finding is consistent with the fact that the main vec-
tor for malaria transmission in Haiti is An. albimanus, 
an outdoor-biting mosquito with a preference for blood 
meals at dawn and dusk [35]. The survey showed that 
those with history of previous infection or with a house-
hold member that is or was infected are twice as likely 
to be positive for sub-microscopic infection. The results 
were statistically significant and come in agreement with 
the observation, that those who are closely associated 
with others infected with malaria are more likely to be 
infected. Finally, travel outside the screening site was a 
protective factor against infection. Further information 
relative to the pattern of travel, the length of absence, and 
travel destination(s) is needed to understand more clearly 
the basis of the protective effect, however it is consistent 
with the interpretation that transmission is focal within 
sites and that travel to other locations in Haiti where 
transmission is lower is protective.
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There is a large variation in malaria prevalence among 
study sites, and these results suggest that using this 
highly sensitive qRT-PCR based survey tool would facili-
tate accurately mapping the reservoirs of malaria across 
the country. Given that samples obtained in a field set-
ting are stable for transportation to established laborato-
ries for rapid completion of the assay, the results can be 
obtained in a timely fashion for mapping purposes and 
for assessing effectiveness of elimination efforts. Obtain-
ing such data will be crucial to effectively guiding the 
utilization of resources available for elimination and eval-
uating success.
Conclusions
The findings of this study demonstrate the superior effi-
cacy of the qRT-PCR as a surveillance tool in detecting 
malaria infections, including submicroscopic infections, 
as compared to other available tools frequently employed 
including PCR. DRS provides a highly useful preserva-
tive for parasite nucleic acids in field conditions, mak-
ing this assay feasible for use under field conditions in 
underdeveloped countries by allowing successful trans-
portation of stabilized samples to established laborato-
ries for analysis. The study identified a large number of 
sub-microscopic infections in Haiti that were not previ-
ously described. Plans for malaria elimination on Hispan-
iola must account for the large number of asymptomatic, 
sub-microscopic infections present in Haitians in regions 
where malaria transmission is found.
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